A randomized, double-blinded, placebo-controlled trial comparing antiretroviral intensification with Maraviroc and Dolutegravir with no intensification or intensification with Dolutegravir alone for the treatment of cognitive impairment in HIV

Project no.: A5324/InMIND (NCT02519777)

Description: n/a